172 related articles for article (PubMed ID: 8014484)
1. Persistence of cell-mediated immunity and decline of humoral immunity to the intracellular bacterium Francisella tularensis 25 years after natural infection.
Ericsson M; Sandström G; Sjöstedt A; Tärnvik A
J Infect Dis; 1994 Jul; 170(1):110-4. PubMed ID: 8014484
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated immunity against Francisella tularensis after natural infection.
Koskela P; Herva E
Scand J Infect Dis; 1980; 12(4):281-7. PubMed ID: 7006062
[TBL] [Abstract][Full Text] [Related]
3. Nature of protective immunity to Francisella tularensis.
Tärnvik A
Rev Infect Dis; 1989; 11(3):440-51. PubMed ID: 2665002
[TBL] [Abstract][Full Text] [Related]
4. Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis.
Kirimanjeswara GS; Olmos S; Bakshi CS; Metzger DW
Immunol Rev; 2008 Oct; 225():244-55. PubMed ID: 18837786
[TBL] [Abstract][Full Text] [Related]
5. Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination.
Poquet Y; Kroca M; Halary F; Stenmark S; Peyrat MA; Bonneville M; Fournié JJ; Sjöstedt A
Infect Immun; 1998 May; 66(5):2107-14. PubMed ID: 9573096
[TBL] [Abstract][Full Text] [Related]
6. Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis.
Golovliov I; Ericsson M; Akerblom L; Sandström G; Tärnvik A; Sjöstedt A
Vaccine; 1995 Feb; 13(3):261-7. PubMed ID: 7631511
[TBL] [Abstract][Full Text] [Related]
7. Development of Francisella tularensis antigen responses measured as T-lymphocyte proliferation and cytokine production (tumor necrosis factor alpha, gamma interferon, and interleukin-2 and -4) during human tularemia.
Surcel HM; Syrjälä H; Karttunen R; Tapaninaho S; Herva E
Infect Immun; 1991 Jun; 59(6):1948-53. PubMed ID: 1674737
[TBL] [Abstract][Full Text] [Related]
8. Immunological markers that correlate with protection immunity against tularemia infection.
Firstova VV; Mokrievich AN; Pavlov VM; Gorbatov AA; Kombarova TI; Biketov SF; Dyatlov IA
Adv Exp Med Biol; 2014; 808():15-23. PubMed ID: 24595607
[TBL] [Abstract][Full Text] [Related]
9. Francisella tularensis-induced in vitro gamma interferon, tumor necrosis factor alpha, and interleukin 2 responses appear within 2 weeks of tularemia vaccination in human beings.
Karttunen R; Surcel HM; Andersson G; Ekre HP; Herva E
J Clin Microbiol; 1991 Apr; 29(4):753-6. PubMed ID: 1909711
[TBL] [Abstract][Full Text] [Related]
10. Francisella tularensis--a model for studies of the immune response to intracellular bacteria in man.
Tärnvik A; Eriksson M; Sandström G; Sjöstedt A
Immunology; 1992 Jul; 76(3):349-54. PubMed ID: 1526645
[No Abstract] [Full Text] [Related]
11. Interleukin 2 and gamma interferon production, interleukin 2 receptor expression, and DNA synthesis induced by tularemia antigen in vitro after natural infection or vaccination.
Karttunen R; Andersson G; Ekre HP; Juutinen K; Surcel HM; Syrjälä H; Herva E
J Clin Microbiol; 1987 Jun; 25(6):1074-8. PubMed ID: 3110207
[TBL] [Abstract][Full Text] [Related]
12. Adaptive Immunity to
Roberts LM; Powell DA; Frelinger JA
Front Cell Infect Microbiol; 2018; 8():115. PubMed ID: 29682484
[No Abstract] [Full Text] [Related]
13. Signatures of T cells as correlates of immunity to Francisella tularensis.
Eneslätt K; Normark M; Björk R; Rietz C; Zingmark C; Wolfraim LA; Stöven S; Sjöstedt A
PLoS One; 2012; 7(3):e32367. PubMed ID: 22412866
[TBL] [Abstract][Full Text] [Related]
14. Vaccine-Mediated Mechanisms Controlling Replication of
Eneslätt K; Golovliov I; Rydén P; Sjöstedt A
Front Cell Infect Microbiol; 2018; 8():27. PubMed ID: 29468144
[TBL] [Abstract][Full Text] [Related]
15. [Tularemia, "volume" two].
Macela A
Epidemiol Mikrobiol Imunol; 1998 Aug; 47(3):103-20. PubMed ID: 9748768
[TBL] [Abstract][Full Text] [Related]
16. GM-CSF has disparate roles during intranasal and intradermal Francisella tularensis infection.
Kurtz SL; Bosio CM; De Pascalis R; Elkins KL
Microbes Infect; 2016 Dec; 18(12):758-767. PubMed ID: 27475899
[TBL] [Abstract][Full Text] [Related]
17. Peripheral human γδ T cells control growth of both avirulent and highly virulent strains of Francisella tularensis in vitro.
Rowland CA; Hartley MG; Flick-Smith H; Laws TR; Eyles JE; Oyston PC
Microbes Infect; 2012 Jul; 14(7-8):584-9. PubMed ID: 22370220
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
[TBL] [Abstract][Full Text] [Related]
19. Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine.
McMurry JA; Gregory SH; Moise L; Rivera D; Buus S; De Groot AS
Vaccine; 2007 Apr; 25(16):3179-91. PubMed ID: 17291638
[TBL] [Abstract][Full Text] [Related]
20. Antigen from Francisella tularensis: nonidentity between determinants participating in cell-mediated and humoral reactions.
Sandström G; Tärnvik A; Wolf-Watz H; Löfgren S
Infect Immun; 1984 Jul; 45(1):101-6. PubMed ID: 6203835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
